
Shares of healthcare giant Pfizer (PFE) have been on a roller coaster ride in recent years. The stock rose from less than $30 in March 2020 to $60 by December 2021, boosted by rising demand for its COVID-19 vaccine. Now, however, PFE is currently priced at $29.48, valuing the company at $162.56 billion by market cap.
